B

BioMark Diagnostics Inc
SWB:20B

Watchlist Manager
BioMark Diagnostics Inc
SWB:20B
Watchlist
Price: 0.202 EUR 6.32%
Market Cap: 18.4m EUR

Operating Margin
BioMark Diagnostics Inc

-1 260%
Current
-1 895%
Average
7.4%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-1 260%
=
Operating Profit
-2m
/
Revenue
155k

Operating Margin Across Competitors

BioMark Diagnostics Inc
Glance View

Market Cap
18.4m EUR
Industry
N/A

BioMark Diagnostics, Inc. engages in development and commercialization of cancer diagnostic solutions to detect, monitor, and assess treatment for cancer. The company is headquartered in Richmond, British Columbia. The company went IPO on 2014-11-03. The Company’s cancer diagnostic solutions can help detect, monitor and assess treatment for cancer. Its cancer diagnostics technology platform leverages Omics and machine learning, which allows for early cancer detection. The firm is focused on bringing its cancer diagnostic kits and detection solution to commercialization standards. Its liquid biopsy assay detects Spermidine/spermine N-acetyltransferase 1 (SSAT1). SSAT1 is an enzyme with elevated levels in numerous cancers. The firm has developed a liquid biopsy metabolic panel assay. This metabolic assay is instrumental for early-stage diagnosis of lung cancer. The liquid biopsy metabolic panel has demonstrated clinical detections. The capabilities include early stage I and II Lung Cancers using urine and plasma.

20B Intrinsic Value
0.004 EUR
Overvaluation 98%
Intrinsic Value
Price
B
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-1 260%
=
Operating Profit
-2m
/
Revenue
155k
What is the Operating Margin of BioMark Diagnostics Inc?

Based on BioMark Diagnostics Inc's most recent financial statements, the company has Operating Margin of -1 260%.

Back to Top